OrbiMed Capital GP VI LLC, 10% Owner, Director at Prelude Therapeutics Inc (PRLD), bought 41,700 shares at $60.00 ($2.5M) on 2021-01-11, disclosed to the SEC on 2021-01-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| IRON | SELL | 2025-03-12 | $32.4M | — | Filing → |
| SCPH | BUY | 2024-08-15 | $2.0M | — | Filing → |
| NPCE | SELL | 2024-04-18 | $435K | — | Filing → |